questionText: To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Department of Health in Northern Ireland on the use of (a) Lecanemab and (b) Donanemab in the treatment of dementia.
answerText: The Department is working closely together with system partners to plan for the implementation of new dementia medicines such as lecanemab and donanemab, should they be granted a marketing authorisation in the United Kingdom and a positive National Instit...
heading: Dementia: Drugs